Francisco, Rezwen .

HRN: 26-60-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
05/08/2026
05/15/2026
PO
2.2ml
BID
Acute Bacterial Infection; T/C Conjunctivitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  BloodstreamEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines